Cantor Fitzgerald Weighs in on DNTH FY2026 Earnings
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Dianthus Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos forecasts that the company will post earnings per share of ($3.44) for the year. The consensus estimate […]
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Dianthus Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst P. Stavropoulos forecasts that the company will post earnings per share of ($3.44) for the year. The consensus estimate […]
